首页> 外文期刊>International Journal of Biomedical Research >Pre-medication with I.V. dexmedetomidine Vs I.V. clonidine in attenuating the pressor response during laryngoscopy & endotracheal intubation
【24h】

Pre-medication with I.V. dexmedetomidine Vs I.V. clonidine in attenuating the pressor response during laryngoscopy & endotracheal intubation

机译:静脉用药前右美托咪定Vs I.V.可乐定可减轻喉镜和气管插管过程中的升压反应

获取原文
           

摘要

Aim of study: This randomized prospective study is done to compare the effects of single premedication dose of I.V dexmedetomidine with IV clonidine in attenuating pressor response to laryngoscopy & endotracheal intubation.Method: Patients were randomly divided into 2 groups of 30 each. Group I patients received clonidine 3 g/kg and Group II patients received Dexmedetomidine 1microgm/kg in 100ml NS 10 min before induction. HR (Heart Rate), SBP (Systolic blood pressure), DBP (Diastolic BP), MAP (Mean Arterial Pressure) were monitored at T0,T1,T2,T3,T4,T5,T6 respectively. Patients were maintained with O2, N2O, Isoflurane and vecuronium at titrated doses.Results: In both the groups patients had attenuation of sympathetic response with decrease in HR and BP. At 1min and 3 min after Intubation rise in HR was more in clonidine group which is statistically significant (p 0.01). Fall in BP was comparable with both groups, after administering the study drug and at induction. At 1, 3, 5, 10 min after intubation both groups showed suppression of SBP, DBP, MAP (p0.05) There was increase in HR in both the groups at 1, 3, 5, 10 min after intubation but increase in HR was more in clonidine group which is statistically significant (p0.01).Conclusion: From this study we conclude that both clonidine and dexmedetomidine attenuates the pressor response during laryngoscopy and Intubation but Dexmedetomidine is better in attenuating the tachycardia response.T0- Basal reading when the patient is shifted to OR, T1- At 5 min after infusion of dexmedetomidine /clonidine, T2- At Induction, T3 to T6 -At 1,3,5 & 10 min after intubation.
机译:研究目的:进行这项随机前瞻性研究,比较I.V右美托咪定和IV可乐定的单次用药剂量对减轻喉镜和气管插管的升压反应的作用。方法:将患者随机分为2组,每组30个。第一组患者在诱导前10分钟内于100ml NS中接受可乐定3 g / kg,第二组患者接受1μg/ kg右美托咪定。分别在T0,T1,T2,T3,T4,T5,T6监测HR(心率),SBP(收缩压),DBP(舒张压),MAP(平均动脉压)。结果:两组患者的交感反应均随着HR和BP的降低而减弱,而滴定剂量的O2,N2O,异氟烷和维库溴铵得以维持。插管后1分钟和3分钟,可乐定组的HR升高更为明显,具有统计学意义(p <0.01)。服用研究药物后和诱导后,两组的血压下降均相当。插管后1、3、5、10分钟,两组均显示出对SBP,DBP,MAP的抑制作用(p> 0.05),插管后1、3、5、10分钟,两组的HR均升高,但HR升高结论:可乐定和右美托咪定均能减轻喉镜和插管过程中的升压反应,而右美托咪定在减弱心动过速反应方面效果更好。T0-输注右美托咪定/可乐定后5分钟,患者转移至T1- T1-,诱导后将T2-转移至OR,插管后1,3,5和10分钟将T3转移至T6-。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号